## Talman Munich: Unveiling Europe’s Cannabis Market Potential
The cannabis industry in Europe is experiencing a seismic shift, and Germany is at the epicenter of this transformation. With the recent implementation of the CanG law, the country is poised to become a key destination for international cannabis investors. To navigate this evolving landscape, the Talman Munich event, scheduled for November 8, 2024, at the Sofitel Munich Bayerpost, will offer invaluable insights into the opportunities and challenges presented by Europe’s dynamic cannabis market.
Focus On Germany’s Regulatory Shift
Germany’s CanG law has fundamentally altered the playing field, making it a focal point for global cannabis investors. Finn Hänsel, the managing director and founder of Sanity Group, will deliver a keynote address focusing on the implications of Germany’s new regulations and the immense potential that the market holds. As a seasoned entrepreneur with multiple successful ventures under his belt, Hänsel’s expertise will offer attendees a comprehensive understanding of the opportunities and hurdles within Germany’s evolving legal framework.
Navigating Europe’s Cannabis Markets
The cannabis market is not limited to Germany; it spans across Europe, presenting both exciting prospects and complex regulatory challenges. Peter Homberg, a partner at Dentons and the head of the European Cannabis Group, will shed light on the intricacies of investing in various European markets, including Germany, Switzerland, the Netherlands, and Spain. Homberg’s presentation will provide a detailed overview of recent investment trends, emerging opportunities, and the obstacles presented by diverse national regulations.
Raising Capital In A Competitive Market
The legalization of cannabis in Germany has spurred intense competition within the market, making securing investments paramount for companies seeking to scale their operations. A dedicated panel discussion featuring Kai-Friedrich Niermann of Kfn+ Law Office and Will Muecke of Artemis Growth Partners will provide valuable insights into strategies for navigating this competitive landscape. Their expertise will equip attendees with the knowledge they need to attract capital and solidify their positions in Germany’s rapidly growing cannabis sector.
Evolving Investment Trends
The global cannabis investment landscape is constantly evolving, influenced by factors like Germany’s new regulations and developments in the U.S. market. David Hyde, founder of Hyde Advisory & Investments, will lead a discussion exploring these dynamic trends and their impact on investment decisions. This session promises to provide practical insights for investors and businesses seeking to adapt to the ever-changing investment climate.
Fireside Chat With DEMECAN’s Dr. Cornelius Maurer
Dr. Cornelius Maurer, co-founder of DEMECAN, a prominent player in Germany’s medical cannabis sector, will participate in a fireside chat with Alex Rogers, founder of the International Cannabis Business Conference (ICBC). Together, they will delve into the intricacies of Germany’s cannabis market and explore the future trajectory of the European industry.
Networking And Pitch Opportunities
Beyond the insightful presentations and discussions, the event will offer invaluable networking opportunities for attendees. A dedicated pitch session will provide a platform for cannabis companies to showcase their business strategies and innovative solutions to potential investors. This platform will offer attendees a chance to evaluate new investment opportunities in both the European and North American markets.
Event Details:
*
Date:
November 8, 2024*
Location:
Sofitel Munich Bayerpost, Munich, Germany*
Tickets:
Available exclusively to Talman House membersTalman Munich is poised to be a pivotal event for anyone seeking to understand the transformative potential of Europe’s cannabis market. With its focus on Germany’s regulatory shift, investment strategies, and the future of the industry, the event promises to deliver valuable insights and connections that will shape the future of cannabis in Europe.
